These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 29755472)

  • 1. The Elusive Anti-
    Tso GHW; Reales-Calderon JA; Pavelka N
    Front Immunol; 2018; 9():897. PubMed ID: 29755472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy: a potential adjunctive treatment for fungal infection.
    Kullberg BJ; van de Veerdonk F; Netea MG
    Curr Opin Infect Dis; 2014 Dec; 27(6):511-6. PubMed ID: 25304393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging drugs and vaccines for candidemia.
    Moriyama B; Gordon LA; McCarthy M; Henning SA; Walsh TJ; Penzak SR
    Mycoses; 2014 Dec; 57(12):718-33. PubMed ID: 25294098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vulvovaginal candidosis: contemporary challenges and the future of prophylactic and therapeutic approaches.
    Chew SY; Than LT
    Mycoses; 2016 May; 59(5):262-73. PubMed ID: 26765516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects.
    Cassone A
    BJOG; 2015 May; 122(6):785-794. PubMed ID: 25052208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent vulvovaginal candidiasis.
    Sobel JD
    Am J Obstet Gynecol; 2016 Jan; 214(1):15-21. PubMed ID: 26164695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative investigation of azole susceptibility in Candida isolates from vulvovaginal candidiasis and recurrent vulvovaginal candidiasis patients in Ghana.
    Adjapong G; Hale M; Garrill A
    Med Mycol; 2017 Aug; 55(6):686-689. PubMed ID: 27838642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis.
    Ge G; Yang Z; Li D; Zhang N; Chen B; Shi D
    Front Immunol; 2022; 13():959740. PubMed ID: 35967437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vulvovaginal candidiasis: An old disease with new challenges].
    Miró MS; Rodríguez E; Vigezzi C; Icely PA; Gonzaga de Freitas Araújo M; Riera FO; Vargas L; Abiega C; Caeiro JP; Sotomayor CE
    Rev Iberoam Micol; 2017; 34(2):65-71. PubMed ID: 28431891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candida vaccines development from point view of US patent application.
    Wang SJ
    Hum Vaccin; 2011 Nov; 7(11):1165-71. PubMed ID: 22048114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candidemia in Adults at a Tertiary Hospital in China: Clinical Characteristics, Species Distribution, Resistance, and Outcomes.
    Lin S; Chen R; Zhu S; Wang H; Wang L; Zou J; Yan J; Zhang X; Farmakiotis D; Tan X; Mylonakis E
    Mycopathologia; 2018 Aug; 183(4):679-689. PubMed ID: 29572768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vulvovaginal candidiasis in a Flemish patient population.
    De Vos MM; Cuenca-Estrella M; Boekhout T; Theelen B; Matthijs N; Bauters T; Nailis H; Dhont MA; Rodriguez-Tudela JL; Nelis HJ
    Clin Microbiol Infect; 2005 Dec; 11(12):1005-11. PubMed ID: 16307555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candidemia in Colombia.
    Cortés JA; Ruiz JF; Melgarejo-Moreno LN; Lemos EV
    Biomedica; 2020 Mar; 40(1):195-207. PubMed ID: 32220174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host-microbe interaction paradigms in acute and recurrent vulvovaginal candidiasis.
    MacAlpine J; Lionakis MS
    Cell Host Microbe; 2024 Oct; 32(10):1654-1667. PubMed ID: 39389030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive candidiasis in immunocompromised hospitalized patients.
    Sims CR; Ostrosky-Zeichner L; Rex JH
    Arch Med Res; 2005; 36(6):660-71. PubMed ID: 16216647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New immunotherapeutic strategies to control vaginal candidiasis.
    Magliani W; Conti S; Cassone A; De Bernardis F; Polonelli L
    Trends Mol Med; 2002 Mar; 8(3):121-6. PubMed ID: 11879772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct protective host defenses against oral and vaginal candidiasis.
    Fidel PL
    Med Mycol; 2002 Aug; 40(4):359-75. PubMed ID: 12230215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infection.
    Ray A; Ray S; George AT; Swaminathan N
    Cochrane Database Syst Rev; 2011 Aug; (8):CD008739. PubMed ID: 21833970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.